Prepregnancy Dopamine Agonist Treatment Duration as a Predictor of Postpartum Prolactinoma Remission. // Endocrine Practice. – URL: https://www.sciencedirect.com/science/article/pii/S1530891X26009572?dgcid=rss_sd_all
Prepregnancy Dopamine Agonist Treatment Duration as a Predictor of Postpartum Prolactinoma Remission. Endocrine Practice. https://www.sciencedirect.com/science/article/pii/S1530891X26009572?dgcid=rss_sd_all
“Prepregnancy Dopamine Agonist Treatment Duration as a Predictor of Postpartum Prolactinoma Remission.” Endocrine Practice.
@article{article100097,
title = {Prepregnancy Dopamine Agonist Treatment Duration as a Predictor of Postpartum Prolactinoma Remission},
journal = {Endocrine Practice},
url = {https://www.sciencedirect.com/science/article/pii/S1530891X26009572?dgcid=rss_sd_all}
}